Manufacturers Life Insurance Company, The Marker Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.59 - $3.35 $27,982 - $58,956	-17,599 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.68 - $4.85 $3,912 - $7,080	-1,460 Reduced 7.66%	17,599 $51,000
Q3 2019 Nov 12, 2019	BUY	$4.1 - $9.0 $606 - $1,332	148 Added 0.78%	19,059 $100,000
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $97,391 - $149,775	18,911 New	18,911 $150,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $313M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.